Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Renal Transplant Patients with Urinary PECs
NCT04769778Phase 4Unknown
- Start
- Feb 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in Chronic kidney allograft nephropathy (CAN). Status: unknown.
02
Drugs
valsartan
03
Conditions
Chronic kidney allograft nephropathy (CAN)
Beyond the preview
Go deeper on NCT04769778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769778.